The involvement of mitogen-activated protein kinases in the 1α,25-dihydroxy-cholecalciferol-induced inhibition of adipocyte differentiation in vitro

Journal of Nutritional Science and Vitaminology

Volumn 58, Issue 1, 2012, Pages 1-8

  Sakuma, Satoru ^a   Fujisawa, Junji ^a   Sumida, Maki ^a   Tanigawa, Mami ^a   Inoda, Rie ^a   Sujihera, Takuya ^a   Kohda, Tetsuya ^a   Fujimoto, Yohko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

1 ,25 dihydroxy cholecalciferol; 3T3 L1 cells; Adipocyte differentiation; Mitogen activated protein kinases

Indexed keywords

ADIPONECTIN; CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN ALPHA; DEXAMETHASONE; INSULIN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862121484     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.58.1     Document Type: Article

References (30)

1. Larsson B, Svardsudd K, Welin I, Wilhelmsen L, Bjorntorp P, Tibblin G. 1984. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Brit Med J 288: 1401-1404.
2. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
3. Takamura T, Nohara E, Nagai Y, Kobayashi K. 2001. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARγ mRNA expression in 3T3-L1 adipocytes. Eur J Pharmacol 422: 23-29.
4. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. 2001. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 276: 41245-41254.
5. Guerre-Millo M. 2004. Adipose tissue and adipokines: for better or worse. Diabetes Metab 30: 13-19.
6. Morrison RF, Farmer SR. 1999. Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem 32;33: 59-67.
7. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. 2000. Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307.
8. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y, Binétruy B. 2002. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361: 621-627.
9. Klemm DJ, Leitner JW, Watson P, Nesterova A, Reusch JE, Goalstone ML, Draznin B. 2001. Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation. J Biol Chem 276: 28430-28435.
10. Prusty D, Park BH, Davis KE, Farmer SR. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277: 46226-46232.
11. Green H, Kehinde O. 1974. Sublines of mouse 3T3-L1 cells that accumulate lipid. Cell 1: 113-116.
12. Green H, Meuth M. 1974. An established pre-adipose cell line and its differentiation in culture. Cell 3: 127-133.
13. Green H, Kehinde O. 1975. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 5: 19-27.
14. Hypponen E, Power C. 2006. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29: 2244-2246.
15. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE. 2006. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114: 577-583.
16. Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. 2007. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 103: 679-681.
17. 3 receptor-like molecule in ST13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocytes differentiation. J Cell Physiol 135: 545-550.
18. Kawada T, Kamei Y, Sugimoto E. 1996. The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators. Int J Obes Relat Metab Disord 20: S52-S57.
19. 3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells. Life Sci 62: PL205-PL211.
20. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139: 2622-2628.
21. Sakuma S, Nishioka Y, Imanishi R, Nishikawa K, Sakamoto H, Fujisawa J, Wada K, Kamisaki Y, Fujimoto Y. 2010. cis9, trans11-Conjugated linoleic acid differentiates mouse 3T3-L1 preadipocytes into mature small adipocytes through induction of peroxisome proliferator-activated receptor γ. J Clin Biochem Nutr 47: 167-173.
22. Yoshimoto Y, Norman AW. 1986. Biological activity of vitamin D metabolites and analogs: dose-response study of 45Ca transport in an isolated chick duodenum perfusion system. J Steroid Biochem 25: 905-909.
23. Tuohimaa P, Golovko O, Kalueff A, Nazarova N, Qiao S, Syvälä H, Talonpoika R, Lou YR. 2005. Calcidiol and prostate cancer. J Steroid Biochem Mol Biol 93: 183-190.
24. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. 1997. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860-867.
25. Sakamoto T, Woodcock-Mitchell J, Marutsuka K, Mitchell JJ, Sobel BE, Fujii S. 1999. TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 276: C1391-C1397.
26. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. 2006. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281: 11205-11213.
27. Font de Mora J, Porras A, Ahn N, Santos E. 1997. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol 17: 6068-6075.
28. Kim SW, Muise AM, Lyons PJ, Ro HS. 2001. Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J Biol Chem 276: 10199-10206.
29. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274: 2100-2103.
30. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128-5132.